What dose and dosing interval of lactulose syrup should be given to a 12‑year‑old child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lactulose Dosing for a 12-Year-Old Child

For a 12-year-old with constipation, start lactulose at 40–90 mL per day divided into multiple doses, titrating to produce 2–3 soft stools daily. 1

Pediatric Dosing Framework

The FDA-approved pediatric dosing for lactulose in older children and adolescents is straightforward:

  • Total daily dose: 40–90 mL per day (approximately 26–60 g of lactulose) 1
  • Frequency: Divide the total daily dose into 2–4 administrations throughout the day 1
  • Therapeutic target: Adjust the dose to produce 2–3 soft stools per day, which defines adequate response 1

Practical Starting Regimen

Begin with 20 mL (approximately 13 g) twice daily, then titrate upward every 1–2 days based on stool frequency and consistency. 1 This gradual approach minimizes dose-dependent bloating and flatulence, which are very common adverse effects that increase with higher doses. 2

Critical Titration Rules

  • If diarrhea occurs: Reduce the dose immediately 1
  • If diarrhea persists despite dose reduction: Discontinue lactulose 1
  • Underdosing pitfall: The most common treatment failure is using insufficient doses for inadequate duration 3
  • Duration: Functional constipation requires treatment for a prolonged period—often weeks to months—to restore normal colonic motility and prevent relapse 3

Alternative for Severe Constipation or Fecal Impaction

If your 12-year-old presents with fecal impaction (with or without fecal incontinence), first perform fecal disimpaction using high-dose polyethylene glycol (PEG) for the initial few days rather than lactulose. 3 PEG is the preferred agent for disimpaction in children over 6 months of age and is generally better tolerated than lactulose for this indication. 3

Monitoring and Adjustment

  • Assess stool frequency daily: The goal is 2–3 soft (not liquid) stools per day 1
  • Watch for excessive stooling: More than 3 stools per day increases the risk of volume depletion and electrolyte disturbances, particularly hypernatremia 2, 4
  • Common adverse effects: Bloating, flatulence, and cramping are expected but should improve with gradual dose titration 2

Context-Specific Considerations

The evidence provided focuses heavily on adult dosing for hepatic encephalopathy 2, 4, which is not applicable to a typical 12-year-old with constipation. The FDA label explicitly addresses pediatric constipation and provides the dosing range of 40–90 mL/day for older children and adolescents. 1 Research confirms that lactulose is authorized and effective for pediatric constipation, though PEG is often preferred for children over 6 months due to better tolerability. 3

References

Guideline

Lactulose Dosing Guidelines for Adult Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[Constipation in infants and children: How should it be treated?].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2016

Guideline

Lactulose Dosing Strategies for Overt Hepatic Encephalopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.